CTNM
NASDAQ · Pharmaceuticals
Contineum Therapeutics Inc-A
$12.21
+0.10 (+0.83%)
Open$12.07
Previous Close$12.11
Day High$13.09
Day Low$12.07
52W High$16.01
52W Low$3.35
Volume—
Avg Volume213.6K
Market Cap584.47M
P/E Ratio—
EPS$-2.20
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+217.9% upside
Current
$12.21
$12.21
Target
$38.82
$38.82
$27.95
$38.82 avg
$46.43
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 273.32M | 248.64M | 220.16M |
| Net Income | 33.71M | 25.85M | 22.01M |
| Profit Margin | 12.3% | 10.4% | 10.0% |
| EBITDA | 45.63M | 48.42M | 37.59M |
| Free Cash Flow | 26.06M | 26.05M | 25.67M |
| Rev Growth | -0.8% | +22.0% | +2.7% |
| Debt/Equity | 0.64 | 0.69 | 0.58 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |